Summary: GLP-1 receptor agonists do not directly cause irregular periods, but the significant weight loss they produce can temporarily affect menstrual regularity through metabolic and hormonal changes
Second, incremental value must be quantified against established predictors, including maternal age, ovarian response, embryo ploidy status, and standard endometrial assessment, because integration that does not change decision quality adds complexity without benefit [481]
Several practical factors may explain fatigue during GLP-1 therapy: Reduced food intake due to appetite suppression can lead to lower energy consumption Gastrointestinal side effects like nausea can be physically draining Adaptation to metabolic changes as your body adjusts to the medication For people with diabetes who take insulin or sulfonylureas (like gliclazide) alongside GLP-1 medications, low blood glucose (hypoglycaemia) may cause fatigue
Obese and insulin-resistant people will discover Retatrutide helps them get rid of unwanted belly fat much faster while re-wiring a dysfunctional relationship with food and their bodys hunger signals caused by decades of neglectful damage
Treatment The injection is typically administered into the deltoid (shoulder), vastus lateralis (thigh), or ventrogluteal (side of the hip) muscle
Here are the key strategies, along with simple ways to apply them